Evom AI, a Seoul, South Korea-based medical AI startup developing an AI platform focused on cardiology, has raised a seed funding round.
Investors
The company previously raised seed funding from Klim Ventures in September 2025 and has now received additional support from the Korean Ministry of SMEs and Startups through the TIPS Deep Tech program.
Klim Ventures is a venture capital firm and startup accelerator based in Seoul. Founded in 2020, the company focuses on supporting ambitious entrepreneurs in industries such as medical AI, deep tech, and SaaS.
TIPS Deep Tech is a private investment-led technology business support initiative designed to nurture startups with exceptional technology and talent in strategic sectors.
Evom AI Use of funds
The company will use the funding to develop AI solutions for early diagnosis and prediction of cardiovascular diseases, including AI for ECG and echocardiography, and to create a large-scale multimodal dataset.
About Evom AI
Founded early last year, Evom AI develops solutions for the early detection, diagnosis and prevention of cardiovascular diseases. Leveraging automation from proprietary AI models and explainable AI frameworks, Evom AI analyzes ECG and echocardiography data, detects subtle signals, automates measurements, and predicts serious cardiac events before they occur. Headquartered in Seoul, South Korea, Evom AI aims to revolutionize medicine through AI-powered proactive and preventive care.
Financing details
Company: Evom AI, Inc.
High: not disclosed
Cycle: Seed funding / government R&D
Funding date: January 2026
Lead investor: Klim Ventures
Additional investors: Korean government through the TIPS Deep Tech program
Company website: https://www.evom.ai/
Software Category: Medical AI Platform/Cardiology AI
Source: https://www.businesskorea.co.kr/news/articleView.html?idxno=260373